Therapeutic electrical stimulation that avoids undesirable activation

• US 8,209,013 B2
• Filed: 09/14/2006
• Issued: 06/26/2012
• Est. Priority Date: 09/14/2006
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Brooke, M. Jason, Sathaye, Alok S., Dong, Yanting, Walczak, Scott
• Primary Examiner(s): Layno, Carl L
• Assistant Examiner(s): Ghand, Jennifer
• Application Number:
  US11/520,879
• Publication Number:
  US 20080071318A1
• Time in Patent Office: 2,112 Days
• Field of Search: 607/2, 607/9, 607 27- 28
• US Class Current: 607/28
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/3712 Auto-capture, i.e. automatic adjustment of the stimulation threshold

Abstract

Energy parameters for electrical stimulation pulses that produce a desired activation, and avoid an undesirable activation, are determined. A strength-duration relationship for at least one desired activation produced by therapeutic electrical stimulation is measured. A strength-duration relationship for at least one undesirable activation produced by the therapeutic electrical stimulation is provided. A medical device selects, based on the desired and undesirable strength-duration relationships, one or more energy parameters for the therapeutic electrical stimulation that produce the desired activation and avoid the undesirable activation.

Claims

1. A therapy device, comprising:

electrodes configured to deliver therapeutic electrical stimulation;

measurement circuitry configured to measure a capture threshold during a capture threshold test, to modify at least one capture threshold test energy parameter based on a strength-duration relationship for at least one undesirable nerve or muscle activation, to perform an additional capture threshold test to determine an additional capture threshold using the modified test energy parameter, and to determine energy parameters for the therapeutic electrical stimulation that produce capture and avoid the undesirable nerve or muscle activation using the additional capture threshold; and

a therapy control processor configured to use the energy parameters for delivery of the therapeutic electrical stimulation;

wherein the modified test energy parameter comprises a pulse amplitude set to an undesirable nerve or muscle activation threshold which is based on the strength-duration relationship for the undesirable nerve or muscle activation.

2. A device of claim 1, wherein:

the electrodes are electrically coupled to a heart;

the therapeutic electrical stimulation comprises pacing pulses to the heart; and

the measurement circuitry comprises circuitry configured to measure the strength-duration relationship of the undesirable activation.

3. The device of claim 1, wherein:

the strength-duration relationship for undesirable activation comprises a multiple-point strength-duration curve for undesirable activation.

4. The device of claim 1, wherein the undesirable activation comprises activation of a phrenic nerve.

5. The device of claim 1, wherein the undesirable activation comprises muscle activation.

6. The device of claim 1, wherein the at least one modified test energy parameter comprises a pulse width.

7. The device of claim 1, wherein the at least one modified test energy parameter comprises a pulse amplitude.

8. The device of claim 1, wherein the measurement circuitry is configured to determine a desired activation strength-duration curve based on pulses of delivered therapeutic electrical stimulation that produced the desired activation, and the measurement circuitry is configured to determine the undesirable activation strength-duration curve based on multiple pulses of delivered therapeutic electrical stimulation that produced the undesirable activation.

9. The device of claim 1, wherein the strength-duration relationship for undesirable activation is based on population data.

10. The therapy device of claim 1, wherein the measurement circuitry is configured to perform the additional capture threshold test by increasing a pulse width until capture is detected.